Accelrys Biological Registration: Mastering Biological R&D at Its Roots
White Paper Nov 25, 2010
This IDC Health Insights Perspective highlights a new product solution that promises to more effectively register, track, and manage promising biologics, resulting in more efficient biological product development and more systematic intellectual property management and protection. Accelrys' new Biological Registration system is the next step in the extension of its Accord chemical registration capabilities to biological entity registration. With the expanded product portfolio from its proposed merger with Symyx Technologies, Accelrys becomes the dominant industry leader for chemical and biological registration solutions, taking chemical and biologic entity management to a new level.
Related White Papers
Identifying biomarkers that predict which patient populations are most likely to respond to a particular treatment can increase the chances of a new investigational drug ultimately entering the market. In this whitepaper, you will discover how advanced bioinformatics can help you overcome biomarker discovery challenges.READ MORE